unknown
Stage
1
Investors
About
Develops AI-enabled breath-based diagnostics that detect disease by analyzing volatile organic compounds (VOCs) in exhaled breath, providing non-invasive, real-time detection capabilities.
Explore Enosemi's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.